Press Release / Media Release

| Updated on January 31, 2018 Published on November 30, 2017

Panacea Biotec Ltd. has delighted to announce that its abbreviated new drug application (ANDA) submitted under section 505(j) of the Federal Food, Drug and Cosmetic Act (FD&C Act) for Paclitaxel Protein Bound Particles for injectable Suspension, 100mg/vial has been accepted for filing by the U.S. Food and Drug Administration (FDA).

A copy of the Press Release being issued to the media, etc. in this regard is enclosed for your kind reference and record please.

Pdf Link: Press Release / Media Release

Source : BSE - www.bseindia.com

Published on November 30, 2017
This article is closed for comments.
Please Email the Editor